| Using Mobile Phone Short Message Service (SMS) Reminders to Enhance Appointment Attendance in DM Patients (NCT03055702) | The University of Hong Kong | 2016-11-01 |
| Diabetic Artery Obstruction: is it Possible to Reduce Ischemic Events With Cilostazol? (NCT02983214) | University of Ioannina | 2016-11-01 |
| Epigenetics of Muscle Insulin Resistance (NCT03259984) | University of Arizona | 2016-11-01 |
| ENhancing Outcomes Through Goal Assessment and Generating Engagement in Diabetes Mellitus (NCT02910089) | AstraZeneca | 2016-10-20 |
| Phase 3 Alogliptin Pediatric Study (NCT02856113) | Takeda | 2016-10-14 |
| A Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of Faster-acting Insulin Aspart in Subjects With Type 2 Diabetes Mellitus (NCT02933853) | Novo Nordisk A/S | 2016-10-14 |
| Effects of Empagliflozin on Left Ventricular Diastolic Function Compared to Usual Care in Type 2 Diabetics (NCT02932436) | Johannes Gutenberg University Mainz | 2016-10-10 |
| GLP1-imaging Before and After Bariatric Surgery (NCT03182231) | Radboud University Medical Center | 2016-10-07 |
| Extension to Study 200952 to Evaluate the Long-term Safety, Tolerability and Pharmacodynamics of Albiglutide Liquid Drug Product in Type 2 Diabetes Mellitus Subjects (NCT02750930) | GlaxoSmithKline | 2016-10-07 |
| Effect of Anti-diabetic Drugs on Glycemic Variability (NCT02925559) | Centro de Diabetes Curitiba Ltda | 2016-10-01 |
| Cardiorespiratory Parameters and Glycated Hemoglobin of Patients With Type 2 Diabetes After a Rehabilitation Program (NCT03094767) | União Educacional do Norte | 2016-10-01 |
| Treatment of Diabetes in Patients With Systolic Heart Failure (NCT02920918) | Virginia Commonwealth University | 2016-10-01 |
| The Effects of Metformin on Self-selected Exercise Intensity, Physical Fitness and Exercise-induced AMPK-activation (NCT02951260) | Rigshospitalet, Denmark | 2016-10-01 |
| Short-term Effects of Perindopril-amlodipine Versus Perindopril-indapamide in Type 2 Diabetes (NCT03747978) | Yaounde Central Hospital | 2016-10-01 |
| The Effect of HMG-CoA Reductase Inhibition on Postprandial GLP-1 Secretion (NCT03018444) | University Hospital, Gentofte, Copenhagen | 2016-10-01 |
| Enhancing Self-Management Support in Diabetes Through Patient Engagement (NCT02834923) | University of California, San Francisco | 2016-10-01 |
| PROTOCOL 3: Role of the Renal Nerves in the Increase in EGP in Response to Glucosuria (NCT03168295) | The University of Texas Health Science Center at San Antonio | 2016-10-01 |
| Effect of Escalating Oral Vitamin D Replacement on HOMA-IR in Vitamin D Deficient Type 2 Diabetics (NCT04183257) | King Edward Medical University | 2016-09-30 |
| Linagliptin Add-on to Insulin Background Therapy (NCT02897349) | Boehringer Ingelheim | 2016-09-30 |
| Salud y Vida 2.0: Enhancing Integrated Behavioral Health for Diabetics in the Rio Grande Valley (NCT04035395) | The University of Texas Health Science Center, Houston | 2016-09-29 |
| An Exploratory Study on the Effects of Repeat Doses of Albiglutide Compared to Exenatide on Gastric Myoelectrical Activity and Gastric Emptying in Type 2 Diabetes Mellitus Subjects (NCT02793154) | GlaxoSmithKline | 2016-09-26 |
| A Double-blinded Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide and Insulin Degludec Both in Combination With Metformin in Japanese Subjects With Type 2 Diabetes Mellitus Inadequately Controlled With Basal or Pre-mix/Combination Insulin Therapy and Oral Anti-diabetic Drugs (NCT02911948) | Novo Nordisk A/S | 2016-09-21 |
| A 38 Week Trial Comparing Effect and Safety of Insulin Degludec/Insulin Aspart vs. Insulin Glargine Plus Insulin Aspart in Subjects With Type 2 Diabetes Treated With Basal Insulin With or Without Oral Antidiabetic Treatment in Need of Treatment Intensification (NCT02906917) | Novo Nordisk A/S | 2016-09-20 |
| Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes Mellitus Treated With Diet and Exercise Only (NCT02906930) | Novo Nordisk A/S | 2016-09-20 |
| Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment (NCT02827708) | Novo Nordisk A/S | 2016-09-20 |
| Efficacy and Safety of Oral Semaglutide Using a Flexible Dose Adjustment Based on Clinical Evaluation Versus Sitagliptin in Subjects With Type 2 Diabetes Mellitus. (NCT02849080) | Novo Nordisk A/S | 2016-09-20 |
| Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose) (NCT02836704) | Sanofi | 2016-09-09 |
| Adaptation of a Cognitive Training Intervention for Diabetes Self-Management (NCT03221452) | University of Texas at Austin | 2016-09-02 |
| Formulas for Diabetes With Sucromalt & Isomaltulose on Glycemic Index, Hormones & Subjective Appetite in Type 2 Diabetes (NCT03829800) | Universidad del Zulia | 2016-09-01 |
| Genetics of Response to Canagliflozin (NCT02891954) | University of Maryland, Baltimore | 2016-09-01 |
| Translation, Cultural Adaptation and Validation of the Creole Versions of the EQ-5D and the SF-36 Questionnaires in Patients With Type II Diabetes in Reunion Island, Martinique and Guadeloupe (NCT02898493) | Centre Hospitalier Universitaire de la Réunion | 2016-09-01 |
| Effect of FISH Intake on MEtabolic Health in a Diabetic South Asian popuLation (FISH MEAL) (NCT02840630) | University of Aberdeen | 2016-09-01 |
| A Phase 2 Trial of IW-1973, A Stimulator of Soluble Guanylate Cyclase (sGC), in Patients With Stable Type 2 Diabetes and Hypertension (NCT02906579) | Cyclerion Therapeutics | 2016-09-01 |
| Liraglutide for HIV-associated Neurocognitive Disorder (NCT02743598) | Temple University | 2016-09-01 |
| QUANtification of Cardiovascular Autonomic Neuropathy (CAN) and the Effects of Anaesthesia on Haemodynamics and Cerebral Perfusion (NCT03071432) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2016-08-30 |
| Investigation of the Effect of Upper Gastrointestinal Disease on the Pharmacokinetics of Oral Semaglutide in Subjects With Type 2 Diabetes. (NCT02877355) | Novo Nordisk A/S | 2016-08-22 |
| Economic Outcomes of EQW (Exenatide Once Weekly) vs. IG (Insulin Glargine) in T2D Patients Who Are New to Injectable Therapy (NCT02843399) | AstraZeneca | 2016-08-15 |
| Efficacy and Safety of Oral Semaglutide Versus Empagliflozin in Subjects With Type 2 Diabetes Mellitus (NCT02863328) | Novo Nordisk A/S | 2016-08-10 |
| JARDIANCE Regulartory Post Marketing Surveillance in Korean Type 2 Diabetes Mellitus (NCT02848833) | Boehringer Ingelheim | 2016-08-10 |
| Efficacy and Safety of Oral Semaglutide Versus Liraglutide and Versus Placebo in Subjects With Type 2 Diabetes Mellitus (NCT02863419) | Novo Nordisk A/S | 2016-08-10 |
| Gastric Ultrasound of Diabetic and Non-Diabetic Patients Following Preoperative Fasting Instructions (NCT02888951) | University Health Network, Toronto | 2016-08-01 |
| Metabolomic Profiling of in Patients With type2 Diabetes (NCT03725709) | Chang Gung Memorial Hospital | 2016-08-01 |
| Mobile Exergaming in Type 2 Diabetes (NCT02657018) | University of Basel | 2016-08-01 |
| Evaluation of Lixisenatide Efficacy in Diabetes Mellitus Type 2 With Failure of Other GLP-1 Analog (NCT02767596) | Laniado Hospital | 2016-07-12 |
| Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-64565111 in Type 2 Diabetes Mellitus (T2DM) (NCT02862431) | Janssen Research & Development, LLC | 2016-07-12 |
| Feasibility Study on the Impact of Economic Incentives to Improve the Management of Type 2 Diabetes Mellitus (NCT02891382) | Universidad Peruana Cayetano Heredia | 2016-07-01 |
| Effect of Roux-en-Y Gastric Bypass or Gastric Sleeve Surgery on Type 2 Diabetes (NCT02713555) | University of Aarhus | 2016-07-01 |
| Serum Sphingolipidomic Analyses in Healthy, Diabetic and Prediabetic Subjects (NCT02826759) | First Affiliated Hospital Xi'an Jiaotong University | 2016-07-01 |
| Integrative Care for Type 2 Diabetes (NCT02843724) | The Canadian College of Naturopathic Medicine | 2016-07-01 |
| SGLT2 Inhibition in Diabetes and Heart Failure (NCT02862067) | Virginia Commonwealth University | 2016-07-01 |
| Effects of SGLT2 Inhibitor on Hemodynamic Parameters in Resistant Hypertensive Subjects (NCT03089333) | University of Campinas, Brazil | 2016-07-01 |
| Effect of DapagliFLOzin on Quality of Life in Patients With Type 2 Diabetes in a Real Clinical PrActice (NCT02719132) | AstraZeneca | 2016-07-01 |
| A Trial Investigating the Influence of Oral Semaglutide on Pharmacokinetics of Ethinylestradiol and Levonorgestrel in an Oral Contraceptive Combination Drug in Healthy Postmenopausal Females (NCT02845219) | Novo Nordisk A/S | 2016-07-01 |
| School-Based Program On Metabolic Disease (NCT03768245) | Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado | 2016-07-01 |
| Canagliflozin (Invokana™) vs. Standard Dual Therapy Regimen for T2DM During Ramadan (NCT02694263) | University of Leicester | 2016-07-01 |
| Low dosE GlibENclamide in Diabetes Part A (NCT02830048) | University of Oxford | 2016-07-01 |
| Physical Activity Behavior Change for Older Adults After Dysvascular Amputation (NCT02738086) | VA Office of Research and Development | 2016-07-01 |
| Dapagliflozin Patient Satisfaction Survey (NCT02805283) | AstraZeneca | 2016-06-22 |
| The T2D Profile - Studies of the Omics Profile in Type 2 Diabetes (NCT06905717) | Göteborg University | 2016-06-15 |
| A Trial Investigating the Effect of Oral Semaglutide Compared With Placebo on Postprandial Glucose and Triglyceride Metabolism, Energy Intake, Appetite Sensations and Gastric Emptying in Subjects With Type 2 Diabetes (NCT02773381) | Novo Nordisk A/S | 2016-06-02 |
| Lifestyle Intervention for Adults With Diabetes (NCT02699307) | University of Michigan | 2016-06-01 |
| Efficacy of Exenatide-LAR and Dapagliflozin in Overweight/Obese, Insulin Treated Patients With Type 2 Diabetes (NCT02811484) | Weill Medical College of Cornell University | 2016-06-01 |
| Effect of Evogliptin on Bone Metabolism in Human (NCT02587975) | DongGuk University | 2016-06-01 |
| The Effect of Acipimox on GLP (Glucagon-like Peptide)-1 Secretion (NCT02796950) | University of Aarhus | 2016-06-01 |
| A Randomized, Placebo-controlled, Double Blind Trial to Investigate Whether Vitamin K2 Can Influence Arterial Calcification in Patients With Type 2 Diabetes (NCT02839044) | UMC Utrecht | 2016-06-01 |
| Dietary Polyphenols and Glycation in Renal Insufficiency (NCT02524938) | NHS Greater Glasgow and Clyde | 2016-06-01 |
| Platelet Inhibition of Ticagrelor Versus Clopidogrel in Type 2 Diabetic Patients After Elective Percutaneous Coronary Intervention (NCT02748330) | Peking Union Medical College Hospital | 2016-06-01 |
| The Effect of DPP4 Inhibitor on Vasclular Healing (NCT02802644) | Chung-Ang University | 2016-06-01 |
| Effect of Low-glycemic Index Meals Intake on DM2 Women Under Metformin Therapy (NCT03165877) | Universidad de Valparaiso | 2016-05-31 |
| FAMS Mobile Health Intervention for Diabetes Self-care Support (NCT02481596) | Vanderbilt University Medical Center | 2016-05-23 |
| A Clinical Trial Comparing Glycaemic Control and Safety of Insulin Degludec/Liraglutide (IDegLira) Versus Insulin Glargine (IGlar) as add-on Therapy to SGLT2i in Subjects With Type 2 Diabetes Mellitus (NCT02773368) | Novo Nordisk A/S | 2016-05-23 |
| Improving Medication Adherence Among Underserved Patients With Type 2 Diabetes (NCT02409329) | Vanderbilt University Medical Center | 2016-05-23 |
| Efficacy and Safety of Toujeo® Versus Tresiba® in Insulin-Naive Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Oral Antihyperglycemic Drug(s) ± GLP-1 Receptor Agonist (NCT02738151) | Sanofi | 2016-05-19 |
| An Extension Study of PEAK Trial (NCT02763007) | Kun-Ho Yoon | 2016-05-18 |
| Shared Medical Visits for Spanish-speaking Patients With Type 2 Diabetes (NCT02836015) | University of Nebraska | 2016-05-13 |
| Cardiovascular Outcomes in Participants With Type 2 Diabetes Mellitus (T2DM) (NCT03249506) | Janssen Research & Development, LLC | 2016-05-12 |
| The Effect of Iloprost on Capillary Recruitment and Insulin Sensitivity in Type 2 Diabetes (NCT03380325) | Amsterdam UMC, location VUmc | 2016-05-11 |
| Empagliflozin and ACEi- Effects on Hyperfiltration: BETWEEN Study (NCT02632747) | Boehringer Ingelheim | 2016-05-10 |
| Effectiveness of a Case Management Model for Patients With Hypertension and Type II Diabetes in Chile (NCT02762695) | Pontificia Universidad Catolica de Chile | 2016-05-04 |
| Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart and BIAsp 30 in Subjects With Type 2 Diabetes (NCT02762578) | Novo Nordisk A/S | 2016-05-03 |
| Reaching Better Health Study: A Website to Improve Type 2 Diabetes Self-Management (NCT02757937) | Children's Hospital of Philadelphia | 2016-05-01 |
| Effectiveness of Motivational Interviewing on Improving Care for Patients With Type 2 Diabetes in China (NCT04342845) | The University of Hong Kong | 2016-05-01 |
| Dapagliflozin and Cholesterol Metabolism in Type 2 Diabetes (DM2) (NCT03074630) | Amsterdam UMC, location VUmc | 2016-05-01 |
| Teaching: Individual to Increase Adherence to Therapeutic Regimen in Hypertension Arterial and/or Diabetes Type 2 (NCT02758275) | Universidad Industrial de Santander | 2016-04-28 |
| Compliance to HIT-program at Home With the Use of Technology (NCT03166852) | University College of Northern Denmark | 2016-04-27 |
| SGLT2 Inhibition and Left Ventricular Mass (NCT02728453) | Hannover Medical School | 2016-04-27 |
| A Study of the Effectiveness of Xultophy® (Insulin Degludec/Liraglutide) in an Adult Real-world Population With Type 2 Diabetes Mellitus (NCT02754817) | Novo Nordisk A/S | 2016-04-26 |
| PANDIA IRIS: Patients With Diabetes and Kidney Failure, an Interdisciplinary Medication Adherence Support Program (NCT04190251) | Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland | 2016-04-14 |
| Basal Insulin And Compensation Glycemic In Diabetic Patients In Basal Bolus Outpatient. (NCT03489031) | Associazione Medici Endocrinologi | 2016-04-11 |
| Diabetes Self-Management Education (DSME) and Its Effect on Clinical, Psychosocial, and Behavioral Outcomes (NCT03185689) | Jimma University | 2016-04-04 |
| An Observational Study to Evaluate Tolerability of Canagliflozin and Sulphonylurea in Type 2 Diabetes Patients During Ramadan (NCT02737657) | Janssen-Cilag International NV | 2016-04-01 |
| CKD-396 Drug-drug Interaction Study(B) (CKD-396 DDI(B) P1) (NCT02827890) | Chong Kun Dang Pharmaceutical | 2016-04-01 |
| Effect of Dairy Consumption on Glycemic Control, Body Weight and Cardiovascular Risk Factors (NCT02896140) | Joslin Diabetes Center | 2016-04-01 |
| The Effectiveness of Diabetes Self-Management Education Program Based on Behavioural Change Theory (NCT02699541) | University of Nottingham | 2016-04-01 |
| Creative Arts Diabetes Initiative for Youth/Young Adults Transitioning to Adult Care (NCT02790892) | University of Manitoba | 2016-04-01 |
| Fecal Microbiota Transplantation for Diabetes Mellitus Type II in Obese Patients (NCT02346669) | Tel-Aviv Sourasky Medical Center | 2016-04-01 |
| Effects of Empagliflozin + Linagliptin vs Metformin + Insulin Glargine on Renal and Vascular Changes in Type 2 Diabetes (NCT02752113) | Institut für Pharmakologie und Präventive Medizin | 2016-04-01 |
| diEtitiaNs Helping pAtieNts CarE for Diabetes (ENHANCED) (NCT02980978) | Minneapolis Heart Institute Foundation | 2016-04-01 |
| An Open-label, Randomized, Crossover Study of Comparative Pharmacokinetics and Bioequivalence of Dapagliflozin + Metformin, 10 mg + 1000 mg Versus the Combined Use of Forxiga™, 10 mg and Two Glucophage® Long, ER Tablets, 500 mg Co-administered to Healthy Volunteers Under Standard Fed Conditions (NCT02722239) | AstraZeneca | 2016-03-30 |
| Efficacy in Controlling Glycaemia With Victoza® (Liraglutide) as add-on to Metformin vs. OADs as add-on to Metformin After up to 104 Weeks of Treatment in Subjects With Type 2 Diabetes (NCT02730377) | Novo Nordisk A/S | 2016-03-28 |